Correlation Between CBrain AS and XSpray Pharma

Can any of the company-specific risk be diversified away by investing in both CBrain AS and XSpray Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CBrain AS and XSpray Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between cBrain AS and XSpray Pharma AB, you can compare the effects of market volatilities on CBrain AS and XSpray Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CBrain AS with a short position of XSpray Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of CBrain AS and XSpray Pharma.

Diversification Opportunities for CBrain AS and XSpray Pharma

-0.43

Correlation Coefficient

CBrain AS  XSpray Pharma

Very good diversification

The 3 months correlation between CBrain and XSpray is -0.43. Overlapping area represents the amount of risk that can be diversified away by holding cBrain AS and XSpray Pharma AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on XSpray Pharma AB and CBrain AS is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on cBrain AS are associated (or correlated) with XSpray Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of XSpray Pharma AB has no effect on the direction of CBrain AS i.e., CBrain AS and XSpray Pharma go up and down completely randomly.

Pair Corralation between CBrain AS and XSpray Pharma

Assuming the 90 days trading horizon cBrain AS is expected to generate 0.61 times more return on investment than XSpray Pharma. However, cBrain AS is 1.64 times less risky than XSpray Pharma. It trades about -0.04 of its potential returns per unit of risk. XSpray Pharma AB is currently generating about -0.09 per unit of risk. If you would invest  24,850  in cBrain AS on September 12, 2024 and sell it today you would lose (4,150) from holding cBrain AS or give up 16.7% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	99.22%
Values	Daily Returns

cBrain AS  vs.  XSpray Pharma AB

cBrain AS

Risk-Adjusted Performance

2 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in cBrain AS are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unsteady basic indicators, CBrain AS may actually be approaching a critical reversion point that can send shares even higher in January 2025.

XSpray Pharma AB

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days XSpray Pharma AB has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, XSpray Pharma is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with CBrain AS and XSpray Pharma

The main advantage of trading using opposite CBrain AS and XSpray Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CBrain AS position performs unexpectedly, XSpray Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in XSpray Pharma will offset losses from the drop in XSpray Pharma's long position.

The idea behind cBrain AS and XSpray Pharma AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.